Glory Adebayo | Parasitology | Best Researcher Award

Ms. Glory Adebayo | Parasitology | Best Researcher Award

Research Associate at Nigerian Institute of Medical Research, Nigeria

Glory Pipeloluwa Adebayo is a dedicated biomedical researcher specializing in molecular biology, bioinformatics, and malaria drug discovery. She is currently a Research Fellow at the Nigerian Institute of Medical Research (NIMR), where she leads studies on Plasmodium falciparum resistance and antimalarial therapeutics. With extensive expertise in molecular diagnostics, immunology, and in vitro drug assays, she has contributed significantly to infectious disease research. Her work has resulted in multiple high-impact publications, and she has trained several young scientists in laboratory techniques. She has also participated in international research collaborations, including training at the Swiss Tropical and Public Health Institute. Her contributions to malaria research extend to both computational and laboratory-based studies, making her a prominent figure in the field. She aspires to develop innovative treatment strategies for infectious diseases through interdisciplinary research and technological advancements.

Professional Profiles📖

Scopus

Education 🎓

Glory is a dedicated researcher with a strong academic background in biological sciences. She earned her B.Sc. (Hons) in Biochemistry from the University of Lagos, Nigeria, with a commendable GPA of 4.08/5.00. She then pursued an M.Sc. in Cell Biology and Genetics at the same institution, graduating with a stellar GPA of 4.29/5.00. Currently, she is completing her Ph.D. in Biology at Covenant University, where her research is centered on antimalarial drug discovery. Her work integrates both computational and laboratory-based approaches to experimental drug development, positioning her at the forefront of innovative biomedical research. Beyond her academic achievements, Glory has gained valuable hands-on experience, including her service at the Abia State Hospital and Diagnostic Centre during her National Youth Service Corps (NYSC) year. She has honed her expertise in molecular techniques, bioinformatics, and pharmaceutical research, contributing to international collaborations, conference presentations, and high-impact scientific publications. With a passion for advancing global health through cutting-edge research, she remains committed to making significant contributions to drug discovery and disease treatment.

Awards and Honors 🏆

Glory’s dedication to research, international collaboration, and academic excellence in biomedical sciences is evident through her numerous prestigious awards and fellowships. In 2024, she was awarded a Research Fellowship at the Nigerian Institute of Medical Research (NIMR), recognizing her contributions to malaria therapeutic efficacy studies and molecular diagnostics. Her commitment to global health research was further acknowledged in 2022 when she received the Swiss TPH Training Fellowship at the Swiss Tropical and Public Health Institute, where she honed her expertise in Plasmodium falciparum drug assays and mammalian cell culture techniques. Earlier in her career, Glory was recognized as the Best Graduate Research Intern at NIMR in 2019 for her outstanding work in molecular diagnosis and Plasmodium resistance studies. Her academic excellence was also celebrated at the University of Lagos, where she received the Academic Excellence Award in 2016. These accolades highlight her passion for scientific discovery, her ability to excel in competitive research environments, and her ongoing contributions to biomedical science and infectious disease research.

Work Experience💼

Glory’s research experience spans academia, public health institutions, and international research centers, showcasing her interdisciplinary expertise in infectious disease research. Currently serving as a Research Fellow at the Nigerian Institute of Medical Research (NIMR), she leads malaria therapeutic efficacy studies, molecular diagnostics, and ELISA-based immunological assessments. Prior to this, she worked as a Research Assistant at Covenant University’s Bioinformatics Research Unit, where she conducted Plasmodium and mammalian cell cultures, toxicity assays, and molecular docking analyses. Her commitment to advancing malaria research led her to the Swiss Tropical & Public Health Institute in 2022, where she received specialized training in Plasmodium falciparum drug assays and mammalian cell culture techniques. She also gained hands-on experience as a Graduate Research Intern at NIMR in 2019, assisting in the molecular diagnosis of human blood samples and Plasmodium resistance studies. Beyond her research-focused roles, she worked as a Pharmacy Assistant at Crest Health Pharmacy in 2017, managing drug inventory and supporting pharmaceutical services. With a solid foundation in both laboratory and clinical research, Glory continues to contribute meaningfully to global infectious disease control efforts.

Skills💡

Glory possesses a diverse skill set that spans molecular biology, cell culture, immunology, bioinformatics, animal studies, lab management, and scientific writing. Her expertise in molecular biology includes DNA/RNA extraction, PCR, gel electrophoresis, and molecular docking, enabling her to conduct precise genetic and protein-based analyses. She is also proficient in cell culture techniques, working with Plasmodium and mammalian cells to perform in vitro drug assays that contribute to antimalarial drug discovery. Her immunology experience includes ELISA-based assays and serological testing, crucial for evaluating immune responses in infectious disease research. In bioinformatics, she specializes in data mining, next-generation sequencing (NGS) analysis, and omics data integration, allowing her to analyze large-scale biological data sets. Additionally, she has hands-on experience with murine malaria models, conducting toxicity assays and drug efficacy testing to validate therapeutic interventions. Beyond her technical skills, Glory is adept at lab management, ensuring compliance with safety protocols, maintaining accurate data records, and developing standard operating procedures (SOPs). She is also an accomplished scientific writer, with experience in manuscript preparation, grant writing, and proposal development, reinforcing her ability to contribute to high-impact research publications and secure funding for innovative projects.

Research Focus 🔬

Glory Adebayo is a dedicated researcher specializing in malaria research, with a focus on molecular drug discovery, Plasmodium resistance characterization, and bioinformatics applications. Her work integrates computational drug design, in vitro and in vivo antimalarial assays, and genetic analysis of resistant strains to advance the fight against malaria. She is particularly interested in post-GWAS (genome-wide association study) analysis, where she develops omics-based tools to study malaria epidemiology and identify potential therapeutic targets.

Beyond malaria research, Glory has contributed to studies on viral infections and antimicrobial resistance, expanding her impact within infectious disease research. Her interdisciplinary approach seamlessly combines wet-lab techniques with computational biology, enabling her to bridge experimental and computational methodologies. Through her research, she aims to develop effective therapeutics and innovative strategies to combat infectious diseases, ultimately improving global public health outcomes.

Publications Top Notes📚

 

Title: The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery.

Journal: Pharmaceuticals.Preprints+1MDPI+1

Publication Date: March 2025.

DOI: 10.3390/ph18030424.

Gul Bayram | Microbiology | Best Researcher Award

Ms. Gul Bayram | Microbiology | Best Researcher Award

Dr at Mersin University, Turkey

Gül Bayram is an Associate Professor in Medical Microbiology, specializing in infectious diseases and molecular diagnostics. She has contributed significantly to research on beta-lactamase activity, mycobacteria identification, and antimicrobial resistance. With over two decades of experience in academia, she has held key positions in research projects and administrative roles. Dr. Bayram has published extensively in high-impact journals and has been a pivotal figure in national and international scientific collaborations. She is also actively involved in science communication, contributing to various academic conferences and symposiums.

Professional Profiles📖

ORCID

Education 🎓

Dr. Gül Bayram holds a Ph.D. in Medical Microbiology from Mersin University (2013), where their research focused on beta-lactamase activity in Enterobacteriaceae, contributing valuable insights into antibiotic resistance mechanisms. Prior to this, they earned a Master’s degree in Medical Microbiology (2007) from the same institution, specializing in identifying mycobacteria using PCR-RFLP techniques to enhance diagnostic accuracy for tuberculosis and related infections. Expanding their expertise in genetic research, they completed a Master’s in Medical Biology (2004) at Cukurova University, investigating genetic mutations in phenylketonuria (PKU) patients, which provided critical data for understanding inherited metabolic disorders. Dr. [Your Name] began their academic journey with a Bachelor’s degree in Biology (2001) from Hacettepe University, establishing a strong foundation in the biological sciences that paved the way for their advanced research in microbiology and genetics.

Work Experience💼

Dr. Gül Bayram has an extensive academic career spanning over two decades at Mersin University, where she currently serves as an Associate Professor (2022-Present). Previously, she held positions as an Assistant Professor (2016-2022) and Lecturer (2006-2016), contributing significantly to medical microbiology education and research. Since 2023, she has also been the Head of the Medical Laboratory Techniques Department, playing a key role in shaping curriculum and academic policies. Dr. Bayram has led and participated in numerous national and international scientific projects as a Researcher & Project Leader, advancing studies in infectious diseases, antimicrobial resistance, and molecular diagnostics. Her contributions to both academia and applied research have had a lasting impact on the field.

Awards and Honors 🏆

Dr. Gül Bayram has been widely recognized for her exceptional contributions to scientific research and academia. Her dedication to advancing knowledge in infectious diseases, antimicrobial resistance, and molecular diagnostics has earned her multiple prestigious accolades. She has been a recipient of competitive research grants under Horizon 2020 and TÜBİTAK, enabling her to lead groundbreaking studies that have had a significant impact on the field of medical microbiology. Her expertise and commitment to scientific excellence have also been acknowledged through awards for outstanding contributions to infectious disease research. Beyond her research endeavors, Dr. Bayram actively promotes science communication and public engagement, playing a key role as a lead organizer of the International Mersin Science Night events. Through these initiatives, she fosters scientific awareness and collaboration, inspiring both researchers and the wider community.

Skills💡

Dr. Gül Bayram possesses a diverse skill set that spans microbial identification and molecular diagnostics, enabling precise detection and characterization of infectious agents. She is highly proficient in PCR, RT-PCR, and gene sequencing techniques, utilizing these advanced molecular tools for pathogen detection, genetic analysis, and epidemiological surveillance. Her expertise extends to epidemiological analysis and statistical modeling, which she applies to study disease patterns, assess public health risks, and develop data-driven strategies for infection control. Additionally, she has a strong background in research project management and grant writing, having successfully led multiple national and international scientific projects, securing funding from prestigious organizations such as Horizon 2020 and TÜBİTAK. Beyond research, Dr. Bayram is an advocate for science communication and academic leadership, playing a key role in organizing scientific events, mentoring students, and fostering collaborations that bridge the gap between research and public health initiatives.

Research Focus 🔬

Dr. Gül Bayram’s research is centered on infectious diseases and molecular microbiology, with a particular emphasis on antimicrobial resistance and beta-lactamase activity. She investigates the mechanisms of drug resistance in bacterial pathogens, contributing to the development of more effective diagnostic and treatment strategies. Her expertise extends to the molecular identification of infectious agents, utilizing advanced techniques to detect and characterize microbial pathogens with precision. Dr. Bayram has also been actively involved in SARS-CoV-2 research, focusing on diagnostic methods and epidemiological studies to better understand the spread and impact of the virus. In addition, her work on mycobacterial infections explores their clinical significance, aiding in the diagnosis and management of diseases such as tuberculosis. Her broader research interests include emerging infectious diseases and public health, addressing global health challenges through innovative scientific approaches and interdisciplinary collaborations.

Conclusion✅

Dr. Gül Bayram is a highly accomplished researcher with significant contributions to medical microbiology and infectious disease research. Her extensive publication record, international collaborations, and leadership roles make her a strong candidate for the Best Researcher Award. While she could enhance her impact through further interdisciplinary collaborations and applied research, her achievements to date position her as a leading figure in her field. Given her track record, she is undoubtedly a deserving nominee for this prestigious recognition.

Publications Top Notes📚

The Prevalence of Human Papillomavirus (HPV) Genotypes in the Oral Mucosae of HIV-Positive Individuals: A Systematic Review and Meta-Analysis

Journal: Microorganisms

Year: 2025

DOI: 10.3390/microorganisms13030646

High-risk Human Papillomavirus Infection Prevalence in Non-Malignant Tonsillar Tissue: A Single-Center Cross-Sectional Study

Journal: Journal of Surgery and Medicine

Year: 2023

DOI: 10.28982/josam.7983

2,5(6)-Disubstituted Benzimidazole Ligand-Bearing Platinum Complexes: Synthesis and Investigation of Anticancer Activities

Journal: Ankara Üniversitesi Eczacılık Fakültesi Dergisi

Year: 2023

DOI: 10.33483/jfpau.1239326

Retrospective Evaluation of SARS-CoV-2 Positive Pediatric Cases: Real-Time PCR Cycle Threshold, Epidemiological and Clinical Features

Journal: Mersin Üniversitesi Sağlık Bilimleri Dergisi

Year: 2022

DOI: 10.26559/mersinsbd.1145014

The Role of CD1a Expression in the Diagnosis of Cutaneous Leishmaniasis: Its Relationship with Leishmania Species and Clinicopathological Features

Journal: Dermatologic Therapy

Year: 2021

DOI: 10.1111/dth.14977

Seroprevalence of Asymptomatic Leishmania spp. Carriage Among Blood Donors in a Leishmaniasis-Endemic Area in Turkey

Journal: Flora: The Journal of Infectious Diseases and Clinical Microbiology

Year: 2020

DOI: 10.5578/flora.68443